Literature DB >> 10231733

Melatonin as an antioxidant in retinal photoreceptors.

P L Marchiafava1, B Longoni.   

Abstract

Dark-adapted, single photoreceptors isolated from the frog retina produce reactive oxygen species (ROS) after about 1 min of illumination with saturating light that we verified by their oxidation of preloaded dihydrorhodamine 123 (DHR) into the fluorescent rhodamine 123 (RHO). In this preparation we tested the antioxidant effects of vitamin E and of melatonin. Melatonin at picomolar and low nanomolar concentrations was determined to be 100 times more potent in inhibiting the light-induced oxidative processes than was vitamin E. On the contrary, both compounds exerted potent prooxidant effects at micromolar concentrations that is above the physiological levels of melatonin. This provides evidence that physiological concentrations of melatonin in a living cell may exert protective actions against a natural oxidant stimulus (light). This helps to define the functional role of endogenous melatonin in photoreceptors, which by their physiological characteristics, are among the marked producers of ROS in the organism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231733     DOI: 10.1111/j.1600-079x.1999.tb00582.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  25 in total

1.  Melatonin MT-1-receptor immunoreactivity in the human eye.

Authors:  P Meyer; M Pache; K U Loeffler; L Brydon; R Jockers; J Flammer; A Wirz-Justice; E Savaskan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

2.  Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study.

Authors:  Herminia Pasantes-Morales; Hugo Quiroz; Octavio Quesada
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

3.  Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.

Authors:  Wei Chen; Hui Cao; Qian-Yi Lu; Na Wang; Shu-Zhi Zhao; Xun Xu; Zhi Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  The effects of melatonin on electrical field stimulation-evoked biphasic twitch responses in the ipsilateral and contralateral rat vasa deferentia after unilateral testicular torsion/detorsion.

Authors:  Süreyya Barun; Gülşen Ekingen; Ismail Mert Vural; Zafer Türkyilmaz; Can Başaklar; Nuri Kale; Zeynep Sevim Ercan; Yusuf Sarioğlu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-08       Impact factor: 3.000

Review 5.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

6.  Effects of melatonin on the nitric oxide treated retina.

Authors:  A W Siu; G G Ortiz; G Benitez-King; C H To; R J Reiter
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 7.  Dopamine and retinal function.

Authors:  Paul Witkovsky
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

Review 8.  Melatonin: an underappreciated player in retinal physiology and pathophysiology.

Authors:  Gianluca Tosini; Kenkichi Baba; Christopher K Hwang; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2012-08-31       Impact factor: 3.467

9.  Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor.

Authors:  Kenkichi Baba; Nikita Pozdeyev; Francesca Mazzoni; Susana Contreras-Alcantara; Cuimei Liu; Manami Kasamatsu; Theresa Martinez-Merlos; Enrica Strettoi; P Michael Iuvone; Gianluca Tosini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-14       Impact factor: 11.205

10.  Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.

Authors:  Richard Rosen; Dan-Ning Hu; Violete Perez; Katy Tai; Guo-Pei Yu; Min Chen; Paul Tone; Steven A McCormick; Joseph Walsh
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.